Search - tctmd.com

Displaying 161 - 180 of 463

Sort: Relevancy | Date

News Daily News

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Yael L. Maxwell

April 03, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

Todd Neale

March 08, 2023

Presentation ACC 2023

The STELLAR Phase 3 Trial: A Study of Sotaterceptin Combination with Background Therapy for the Treatment of Pulmonary Arterial Hypertension

Presenter: Marius M. Hoeper

March 05, 2023

News Daily News

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Yael L. Maxwell

February 21, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

Todd Neale

December 23, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

Todd Neale

November 16, 2022

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

Advertisement

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

April 2023 News Roundup

March 2023 News Roundup

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

The STELLAR Phase 3 Trial: A Study of Sotaterceptin Combination with Background Therapy for the Treatment of Pulmonary Arterial Hypertension

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Longer-Term ASCVD Risk Assessment Best for Younger Patients

February 2023 News Roundup

Only Half of Revascularized PAD Patients Receive GDMT

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

Reduction in BP Drives Treatment Preference for Hypertensive Patients

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content